Quality & Safety

Congestive Heart Failure (CHF)

This solution enables the business and clinicians to access appropriate information at appropriate times resulting in reductions in CHF mortality, length of stay, and administration improvements to timely measurements and follow-up appointments.

heartfailure

Congestive Heart Failure (CHF) is a common chronic medical condition that is associated with complications and high mortality rates. This CHF analytic clinical solution will provide the necessary data elements clinically recommended to treat CHF exacerbation.

Congestive heart failure occurs when the heart function is unable to provide sufficient blood flow to the body. CHF hospital visits incur 4.4% mortality and 60% readmission rate. 5.1 million people in the United States have heart failure and about half die within five years of diagnosis.

The program tracks the times of which medical interventions are performed. This data will help to identify potential barriers and trends in treatment plans once CHF exacerbation treatment begins.

Benefits of Fusion Solution include:

  • Care path optimization
  • Best practice alert management
  • Complication avoidance and management
  • Time to Diuertic and BNP are key metrics
  • Echos, Urine analysis etc. helps reducing cost
  • Daily weight management in an acute setting helps manage the disease better
  • Follow-up before discharge within 7 days helps lowering readmission's

Return On Investment from Fusion Solution

  • Reduction in mortality
  • 56-minute reduction in median BNP turnaround
  • 0.18-day reduction in length of stay
  • 267% increase in order set utilization
  • 2-hour reduction in time from door to diuretic
  • 73% increase in daily weight documentation
  • 22% increase in follow-up appointments

Adult Sepsis

Our Sepsis solution helps you improve compliance with SEP-1. We provide practical recommendations to streamline workflows, improve satisfaction and increase data capture. Using your existing IT tools, we also build a powerful, easy-to-use dashboard that provide patient-level detail for performance improvement.



Sepsis is a common acute medical condition that is associated with high mortality rates. Improving the quality of timely medical interventions associated with severe sepsis and septic shock can improve patient outcomes. This sepsis analytic clinical program will provide the necessary data elements clinically recommended to identify and treat severe sepsis and septic shock.

The quality improvement analytic program tracks the times of which medical interventions are performed. This data will help to identify potential barriers and trends in treatment plans once Sepsis protocol begins. The improvement of Sepsis protocol workflows impacts notable hospital KPI’s such as length of stay, readmissions, and mortality rates.

    • This is among the most expensive DRG in most hospitals
    • Highest opportunity to reduce mortality
    • Improve length of stay
    • Reduce readmission, resulting in cost reductions
    • Helps evaluate the 3 and 6 hour bundles
    • Improves core measures
    • Protocols improvement

Benefits of Fusion Solution include:

  • Identifying close outliers from the 3-hour and 6-hour bundles
  • Protocols improvement and “What” they are missing
  • Slow on fluid
  • Overall antibiotic duration tracking and management

Return On Investment from Fusion Solution

  • 27% reduction in mortality rate
  • 25% reduction in readmissions
  • 16- hour reduction in critical care length of stay
  • 14.6% improvement in antibiotic administration in first 3 hours
  • 14.8% improvement in timely lactate measurement
  • Reduction in average time to each important clinical action

Pediatric Sepsis

This solution tracks the times at which medical interventions are performed. This data will help to identify potential barriers and trends in treatment plans once Sepsis protocol begins. The improvement of Sepsis protocol workflows impacts notable hospital KPI’s such as length of stay, readmissions, and mortality rates.

sepsis

An analytic clinical program that will provide the necessary data elements clinically recommended to identify and treat severe sepsis and septic shock. Fusion participated with a charter hospital in the "Improving Pediatric Sepsis Outcomes” effort with the Children’s Hospital Association.

Benefits of Fusion Solution include:

  • Applicable for all participants in Improving Pediatric Sepsis Outcomes (IPSO) Collaborative
  • Implemented for and automated for a Collaborative Member based on guidelines
  • Data specifications were iteratively worked with CHA through prior implementation
  • Complex implementation shortened based on prior experience with CHA Sepsis Collaborative member’s specifications

Ambulatory Quality

Our Ambulatory Quality solution focuses on two main areas of Ambulatory quality. Population management (preventative care management) and chronic disease management are the focal point of Fusion’s Ambulatory Care analytic solutions.

ambulatory

In an everchanging healthcare environment Fusion’s Ambulatory care focuses on the resolution of care gaps and the improvement of clinical practice guidelines for continual improvement with Population Health Management and Chronic Disease Management. Our solution helps identify care gaps thus mitigating the opportunity for adverse events and provide data for several quality improvement programs such as HEDIS, Medicare STAR, Accountable Care Organizations (ACO), and PQRS.

Data, strategy, and collaboration are key to improving the efficacy of care provided to improve outcomes and reduce the cost of managing large patient populations.

Improving preventive care and on-going ambulatory care of chronic disease patients improves patient outcomes and reduces hospital visits and cost. Different Ambulatory care programs are vital to payor contracts and incentives. Problem areas of ambulatory include:

    • Poor Management of Chronic Disease Populations
    • Increased frequency of Hospital and Emergency Department admissions
    • Poor community and population outreach
    • Increased gaps in patient care
    • Delays in treatment and preventative care

Benefits of Fusion Solution include:

  • Gaps in Population Health metrics. Identifying patients who need outreach or resolution of care gaps
  • Pre-built metric definitions with data points needed to help improve speed to deliver reporting
  • Population Health Management metrics (for ACO and Clinically Integrated Networks also)
  • Pay for Performance
  • HEDIS metrics
  • PQRS
  • Medicare STAR reporting
  • Care Management
  • Evaluate and reduce Health risks

Chronic Obstructive Pulmonary Disease (COPD)

Exacerbation of COPD including worsening emphysema and chronic bronchitis (two main types of COPD) can be costly and have grave outcomes for patients. Our solution helps support clinicians to manage COPD patient populations by providing analytics around preventative care and treatment of COPD.



Chronic Obstructive Pulmonary Disease (COPD) makes it difficult for patients to breathe easily. Treatment can be costly and have grave outcomes for patients. Our solution includes:

Ambulatory (Preventative Care Management) Metrics
    • Spirometry testing performed annually
    • Short term and long term bronchodilators medication management
    • Access to pulmonary specialists
    • Timely appointments to address COPD management with PCP’s and Pulmonologist

Exasperated COPD in Acute inpatient
    • Spirometry performed
    • Inhaled Bronchodilators and Steroid medication management
    • Chest X-ray performed upon admission and routine Xrays performed
    • Routine Blood Gases to monitor oxygenation levels
    • Routine Blood Chemistry monitoring
    • Monitor for over-utilization of labs

Benefits of Fusion Solution include:

  • Cost Management based on lab orders
  • Combined reporting of Acute and Ambulatory to manage the COPD
  • Clinical Analytics not constrained by Service lines or Departments for better Population and Disease Management

Readmissions Reduction

Clinicians will be able to study causes and most frequent reasons for readmissions as well as analyze readmissions by service, treatment, DRG and diagnosis. CMS exclusions and non-CMS custom exclusions can be applied. This solution works across all service lines and the health system for consolidated analytics.

readmission

This solution provides the reason for readmission and length of stay impact. Statistical data for outpatient surgery is also available. Hospital readmissions are a systemic issue across all hospitals which affect both patient care and operating costs. With the Readmissions Reductions solution your organization will have access to the analytical tools necessary to properly evaluate readmissions on a variety of levels. Take the necessary steps to reduce patient readmissions.

Benefits of the Fusion Readmissions Reduction Solution

  • Evaluate your organization’s reasons for readmissions
  • Provides clinicians and healthcare leadership with analytical tools and reports to substantiate or change processes and workflows
  • Ability to analyze readmissions by service, treatment, DRG, disposition and diagnosis
  • Ability to easily drill down into details within the dashboards
  • Evaluate readmissions at 7, 30, and 90 days

Stroke

Our comprehensive Stroke solution provides required Joint Commission measures that are aimed at how well an organization provides care to stroke patients. These measures are necessary to become a level 1 certified Stroke center.



Provides Joint Commission Reporting Metrics Including:

STK Metrics:
    • STK-1 Venous Thromboembolism (VTE) Prophylaxis
    • STK-2 Discharged on Antithrombotic Therapy
    • STK-3 Anticoagulation Therapy for Atrial Fibrillation/Flutter
    • STK-4 Thrombolytic Therapy
    • STK-5 Antithrombotic Therapy By End of Hospital Day Two
    • STK-6 Discharged on Statin Medication
    • STK-8 Stroke Education
    • STK-10 Assessed for Rehabilitation

CSTK Metrics:
    • CSTK-01 NIHSS Score Performed for Ischemic Stroke Patients
    • Includes assessments for Stroke order sets & decision support analytics for Level 1 certified Stroke Center.

Benefits of Fusion Solution include:

  • Evidence based process and quality measures to manage Stroke encounters.
  • Provides retrospective analytics that help improve decision support tools, workflows, Stroke order sets, and clinical pathways.
  • All measures necessary to achieve Stroke center certification from the Joint Commission.

Enhanced Recovery After Surgery (ERAS)

Despite improvements in surgical techniques, anesthesia, and other medical improvements, Intra and Post-operative care for Colorectal Surgical patients always provide opportunities for advancement. Clinical evidence based practice indicates that proper ERAS protocols improve post-surgical outcomes.



Evidence based clinical pathway for PRE, INTRA, and POST operative care for Colorectal surgical patients from the American Society of Colon and Rectal Surgeons and is similar to evidence based clinical programs implemented at Duke University. ERAS is meant to reduce length of stay, readmissions, and the occurrences of infections and post-surgical complications.

Benefits of Fusion Solution include:

  • Reduce median length of stay
  • Occurrence of infections
  • Readmission rates reduction
  • Improvement on following clinical pathways intra-operative and post-operatively for Colorectal surgery patients.
  • Monitoring intra-operative and post-operative care for Colorectal surgery patients including clinical guidelines for fluid volume management, appropriate use of opioids for pain management, antibiotic administration, dietary enhancement, and early patient mobilization.

Pediatric Respiratory

Analysis of bronchodilator and steroid ordering, drug administration and medication management for patients with a diagnosis of asthma, bronchiolitis and pneumonia. In addition to these primary medications, the solution also provides analytics on antibiotic management for patients categorized with a pneumonia diagnosis.



Our Pediatric Respiratory solution is segmented into Asthma, Bronchiolitis and Pneumonia.

We dive into the details of bronchodilator and steroid ordering, administration and management. This solution also provides data for the management of intravenous and oral antibiotic medications for patients with a diagnosis of pneumonia. Also helps with efficient use of ventilators

Below is a snapshot of metrics and data elements captured in the Pediatric Respiratory solution.

Asthma

    • Time from arrival to beta-agonist
    • Time from arrival to corticosteroid
    • Percentage of patients receiving
    • Length of stay
    • Readmissions

Bronchiolitis

    • Length of stay
    • Mortality
    • Time from arrival to antibiotic
    • Time from arrival to corticosteroid
    • Mechanical ventilation utilization

Pneumonia

    • Length of stay
    • Mortality
    • Time from arrival to antibiotic
    • Mechanical ventilation utilization

Benefits of Fusion Solution Include:

  • Assessment of turnaround times for bronchodilator, steroid and antibiotic administration
  • Provides Pediatric clinicians and healthcare leadership with analytical tools and reports to substantiate or change processes and workflows
  • Customized visualizations designed to provide an efficient overview of the clinical data and monitor patient outcomes over time.
  • Lab orders optimization to ensure larger than needed panels are not ordered

Congenital Heart Disease

Effectively managing cardiology patient population for interventional surgery improves care, identifies and realizes opportunities for increased revenue and margins.



One in hundred babies have congenital heart defectand roughly 40,000 children are born a year with CHD. It is the leading cause of deaths due to birth defects. This defect can affect the structure or the way heartfunctions. The defect ranges frommild to medium to severe. Severe conditions require surgery immediately and may require lifelong attention. Optimal care varies from occasional monitoring to aggressive interventions based on patient condition specifics.

Key after identifying patient cohort for Congenital Heart Disease involves effective analysis of patient population, managing outreach, defining care plan and engagement for scheduling care and interventions.

Approach recommends a two-step process:

1. Blocking & Tackling – Identify, analyze (semi-automated) and follow up to secure your current CHD population
2. Expansion – Address CHD population from other institutions with better Cardiologist engagement

Benefits of Fusion Solution include:

  • On an average identifying even 4 possible patients from the population helps pay for a provider cost for increased revenue identification and opportunities
  • Average $19k margin per intervention for one patient qualified
  • Algorithm has helped 93% accuracy in identifying the pediatric cardiologists and 78% accuracy in identifying diagnostics and status
  • On review, 35% identified cohorts have missed follow-ups
Switch to desktop version